#1
Posted: Wed Apr 15, 2026 4:40 am
A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly.
Source: https://www.sciencedaily.com/releases/2 ... 022029.htm
Source: https://www.sciencedaily.com/releases/2 ... 022029.htm